Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - it is an in vitro reverse transcription-polymerase chain reaction (rt‑pcr) assay for the quantitation of hepatitis c viral ribonucleic acid (hcv rna) in human serum and plasma from hcv-infected individuals. the abbott realtime hcv assay is intendedfor use as an aid in the management of hcv-infected patients undergoing antiviral therapy. the abbott realtime hcv assay is not for screening blood, plasma, serum or tissue donors for hcv,or to be used as a diagnostic test to confirm the presence of hcv infection.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - it is an in vitro reverse transcription-polymerase chain reaction (rt-pcr) assay for determining the genotype(s) of hepatitis c virus (hcv) in plasma and serum from hcv-infected individuals. the abbott realtime hcv genotype ii is not for screening blood, plasma, serum or tissue donors for hcv, or to be used as a diagnostic test to confirm the presence of hcv infection in donated blood, plasma, serum or tissue.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime high risk hpv is a qualitative in vitro test for the detection of dna from 14 high risk human papillomavirus (hpv) genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 in clinical specimens.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime hiv-1 qualitative is an in vitro amplification assay for the qualitative detection of human immunodeficiency virus type 1 (hiv-1) nucleic acids from human plasma and dried blood spots (dbs). the abbott realtime hiv-1 qualitative is intended to be used as an aid in the diagnosis of hiv-1 infection in pediatric and adult subjects. the abbott realtime hiv-1 qualitative is not intended to be used as a donor screening test for hiv-1. the product has not been evaluated in pregnant or postpartum women.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime hiv-1 assay is an in vitro reverse transcription-polymerase chain reaction (rt-pcr) assay for the quantitation of human immunodeficiency virus type 1 (hiv-1) in human plasma from hiv-1 infected individuals. the abbott realtime hiv-1 assay is intended for use in conjunction with clinical presentation and other laboratory markers as an indicator of disease prognosis and for use as an aid in assessing viral response to antiretroviral treatment as measured by changes in plasma hiv-1 rna levels. this assay is not intended to be used as a screening test for hiv-1 or as a diagnostic test to confirm the presence of hiv-1 infection.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - microbiology - the abbott realtime ebv assay is an in vitro polymerase chain reaction (pcr) assay for the quantitation of epstein-barr virus (ebv) dna in human plasma or whole blood. this assay is not intended to be used as a screening test for ebv or as a diagnostic test to diagnose ebv infection.

Singapur - angielski - HSA (Health Sciences Authority)

abbott laboratories (singapore ) private limited - immunology - the abbott prism next is an automated immunoassay analyzer designed to perform chemiluminescent immunoassay (chlia) technology. the abbott prismnext performs batch/continuous access and stat processing of specimens containing both large and small molecular weight analytes.

Izrael - angielski - Ministry of Health

abbott medical laboratories ltd - acid casein 5.9 g / 100 ml; artificial vanilla 116 mg / 100 ml - liquid - combinations of electrolytes - oxepa is clinically shown to modulate the inflammatory response in critically ill, mechanically ventilated patients. it is appropriate for patients who have sepsis, ali (acute lung injury), or ards (acute respiratory distress syndrome).

Izrael - angielski - Ministry of Health

abbott medical laboratories ltd - niacin 500 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

Izrael - angielski - Ministry of Health

abbott medical laboratories ltd - niacin 750 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n